Glenohumeral Cortisone Injection
Study Details
Study Description
Brief Summary
The objective of this project is to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 2 |
Detailed Description
THis is a randomized control trial to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: Controls Patients receiving lidocaine |
Drug: Lidocaine
Lidocaine injection into shoulder
|
Active Comparator: Cases Patients receiving Kenalog |
Drug: kenalog
Cortisone injection into shoulder
|
Outcome Measures
Primary Outcome Measures
- American Shoulder Elbow Society Score [24 weeks]
Outcome Instrument high is good low is bad 0-100
Secondary Outcome Measures
- Visual Analogue Scale [24 weeks]
pain scale - high is bad - low is good 0-100
Eligibility Criteria
Criteria
Inclusion Criteria:
1.18-90
-
Proximal Humerus Fracture
-
Decreased range of motion at 6 wk follow-up
-
Likely to be available for follow up for 26 wks
Exclusion Criteria:
-
Known drug allergy to kenalog or lidocaine
-
Unable to complete functional outcome
-
Pregnant Women
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Washington | Seattle | Washington | United States | 98104 |
Sponsors and Collaborators
- University of Washington
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Investigators
- Principal Investigator: Jonah Hebert-Davies, MD, University of Washington
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- STUDY00007576
- P30AR072572